ChemBriefChemours Shareholders Solicited for Securities Fraud Class Action Over Opteon Demand Claims
The Law Offices of Frank R. Cruz filed a class action against Chemours alleging misleading statements on Opteon product demand and 2026 guidance, resulting in an 18.63% stock decline.
FinancialContent · 2026-10-09 18:11